Annual Cash & Cash Equivalents
$43.64 M
+$494.40 K+1.15%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual cash & cash equivalents is $43.64 million, with the most recent change of +$494.40 thousand (+1.15%) on December 31, 2023.
- During the last 3 years, CRMD annual cash & cash equivalents has risen by +$1.74 million (+4.15%).
- CRMD annual cash & cash equivalents is now -18.15% below its all-time high of $53.32 million, reached on December 31, 2021.
Performance
CRMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$35.29 M
+$6.75 M+23.63%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly cash and cash equivalents is $35.29 million, with the most recent change of +$6.75 million (+23.63%) on September 30, 2024.
- Over the past year, CRMD quarterly cash and cash equivalents has dropped by -$8.36 million (-19.15%).
- CRMD quarterly cash and cash equivalents is now -53.70% below its all-time high of $76.21 million, reached on March 31, 2021.
Performance
CRMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRMD Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.1% | -19.1% |
3 y3 years | +4.2% | -18.2% |
5 y5 years | +147.6% | -51.7% |
CRMD Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.1% | +1.1% | -33.8% | +79.1% |
5 y | 5-year | -18.1% | +166.9% | -53.7% | +189.1% |
alltime | all time | -18.1% | +5123.5% | -53.7% | >+9999.0% |
CorMedix Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $35.29 M(+23.6%) |
Jun 2024 | - | $28.54 M(-18.9%) |
Mar 2024 | - | $35.18 M(-19.4%) |
Dec 2023 | $43.64 M(+1.1%) | $43.64 M(-18.1%) |
Sep 2023 | - | $53.31 M(+170.6%) |
Jun 2023 | - | $19.70 M(-22.0%) |
Mar 2023 | - | $25.27 M(-41.4%) |
Dec 2022 | $43.15 M(-19.1%) | $43.15 M(-0.2%) |
Sep 2022 | - | $43.25 M(-11.6%) |
Jun 2022 | - | $48.93 M(+7.8%) |
Mar 2022 | - | $45.39 M(-14.9%) |
Dec 2021 | $53.32 M(+27.2%) | $53.32 M(-19.6%) |
Sep 2021 | - | $66.32 M(-9.3%) |
Jun 2021 | - | $73.09 M(-4.1%) |
Mar 2021 | - | $76.21 M(+81.9%) |
Dec 2020 | $41.91 M(+156.3%) | $41.91 M(+21.9%) |
Sep 2020 | - | $34.36 M(+108.3%) |
Jun 2020 | - | $16.49 M(+35.1%) |
Mar 2020 | - | $12.20 M(-25.4%) |
Dec 2019 | $16.35 M(-7.2%) | $16.35 M(-18.8%) |
Sep 2019 | - | $20.15 M(+38.3%) |
Jun 2019 | - | $14.56 M(-20.2%) |
Mar 2019 | - | $18.26 M(+3.6%) |
Dec 2018 | $17.62 M(+69.8%) | $17.62 M(+173.5%) |
Sep 2018 | - | $6.44 M(+37.0%) |
Jun 2018 | - | $4.70 M(-42.4%) |
Mar 2018 | - | $8.16 M(-21.4%) |
Dec 2017 | $10.38 M | $10.38 M(+99.1%) |
Sep 2017 | - | $5.21 M(-34.3%) |
Jun 2017 | - | $7.94 M(+16.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | - | $6.82 M(-15.4%) |
Dec 2016 | $8.06 M(-31.8%) | $8.06 M(-17.9%) |
Sep 2016 | - | $9.83 M(-18.3%) |
Jun 2016 | - | $12.02 M(-8.8%) |
Mar 2016 | - | $13.18 M(+11.6%) |
Dec 2015 | $11.82 M(+172.3%) | $11.82 M(-17.1%) |
Sep 2015 | - | $14.25 M(-40.9%) |
Jun 2015 | - | $24.11 M(+174.0%) |
Mar 2015 | - | $8.80 M(+102.8%) |
Dec 2014 | $4.34 M(+82.8%) | $4.34 M(-26.7%) |
Sep 2014 | - | $5.92 M(-22.6%) |
Jun 2014 | - | $7.65 M(-16.7%) |
Mar 2014 | - | $9.19 M(+287.1%) |
Dec 2013 | $2.37 M(+184.1%) | $2.37 M(+391.4%) |
Sep 2013 | - | $483.10 K(+205.0%) |
Jun 2013 | - | $158.40 K(-77.1%) |
Mar 2013 | - | $692.70 K(-17.1%) |
Dec 2012 | $835.50 K(-57.9%) | $835.50 K(-15.8%) |
Sep 2012 | - | $992.30 K(+11.0%) |
Jun 2012 | - | $893.90 K(-51.8%) |
Mar 2012 | - | $1.86 M(-6.6%) |
Dec 2011 | $1.99 M(-76.0%) | $1.99 M(-31.3%) |
Sep 2011 | - | $2.89 M(-39.0%) |
Jun 2011 | - | $4.74 M(-27.8%) |
Mar 2011 | - | $6.56 M(-20.8%) |
Dec 2010 | $8.28 M(+450.3%) | $8.28 M(-13.0%) |
Sep 2010 | - | $9.52 M(-10.0%) |
Jun 2010 | - | $10.59 M(-9.7%) |
Mar 2010 | - | $11.72 M(+678.9%) |
Dec 2009 | $1.51 M | $1.51 M |
FAQ
- What is CorMedix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CorMedix?
- What is CorMedix annual cash & cash equivalents year-on-year change?
- What is CorMedix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CorMedix?
- What is CorMedix quarterly cash and cash equivalents year-on-year change?
What is CorMedix annual cash & cash equivalents?
The current annual cash & cash equivalents of CRMD is $43.64 M
What is the all time high annual cash & cash equivalents for CorMedix?
CorMedix all-time high annual cash & cash equivalents is $53.32 M
What is CorMedix annual cash & cash equivalents year-on-year change?
Over the past year, CRMD annual cash & cash equivalents has changed by +$494.40 K (+1.15%)
What is CorMedix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRMD is $35.29 M
What is the all time high quarterly cash and cash equivalents for CorMedix?
CorMedix all-time high quarterly cash and cash equivalents is $76.21 M
What is CorMedix quarterly cash and cash equivalents year-on-year change?
Over the past year, CRMD quarterly cash and cash equivalents has changed by -$8.36 M (-19.15%)